Hims & Hers jumps 7% after expanding partnership with Eli Lilly [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
The telehealth firm said clinicians using its platform can now issue prescriptions for Zepbound vials, KwikPen, and Foundayo, which can be fulfilled through the LillyDirect pharmacy. The service includes access to self-pay pricing options for Hims & Hers customers and enables licensed providers to connect patients with FDA-approved GLP-1 therapies. Broader push into GLP-1 treatments The move builds on a prior announcement last month, when Hims & Hers partnered with Novo Nordisk to offer access to Wegovy injections and oral treatments. The company said these initiatives reflect a broader strategic shift in its U.S. weight loss segment, driven by growing demand and evolving market dynamics around GLP-1 medications. Expanded care offering for members Hims & Hers noted that its weight loss program includes a range of support services, such as 24/7 access to care teams, personalized nutrition plans, regular clinical follow-ups, and peer support through its Weight Loss community.
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Here's Why Agios Pharmaceuticals Stock Slumped This Week (And What Investors Have to Look Forward to in 2026) [Yahoo! Finance]Yahoo! Finance
- How Dave Ricks keeps Lilly looking beyond its hit weight loss drugs [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk A/S (NVO) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Hims stock price reacts strongly to crucial FDA review [Yahoo! Finance]Yahoo! Finance
- Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap? [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 4/20/26 - Form 6-K
- 4/20/26 - Form 6-K
- 4/13/26 - Form 6-K
- NVO's page on the SEC website